A Study to Investigate Leramistat in Patients With IPF
Open the official record
This page only displays public information reproduced from the official ClinicalTrials.gov record NCT05951296. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study to Investigate the Efficacy and Safety of Leramistat in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To compare the effect of daily oral dosing of leramistat over 12 weeks with placebo in participants aged 40 years or older with idiopathic pulmonary fibrosis (IPF).
Study identification
- NCT ID
- NCT05951296
- Recruitment status
- Withdrawn
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- Not listed
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 40 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 30, 2023 (Actual)
- Primary completion
- Feb 27, 2024 (Actual)
- Completion
- Mar 14, 2024 (Actual)
- Last update posted
- Apr 9, 2025
2023 – 2024
United States locations
- U.S. sites
- 21
- U.S. states
- 13
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| UCSF Fresno | Fresno | California | 93701-2302 | — |
| National Jewish Health Main Campus | Denver | Colorado | 80206-2761 | — |
| MedStar Georgetown University Hospital | Washington D.C. | District of Columbia | 20007 | — |
| Reliant Medical Research | Miami | Florida | 33165 | — |
| US Associates in Research Inc | Miami | Florida | 33175 | — |
| GCP Clinical Research, LLC | Tampa | Florida | 33609-3589 | — |
| GCP Clinical Research | Tampa | Florida | 33609-3589 | — |
| Southern Medical Research, LLC | Macon | Georgia | 31201-8334 | — |
| GenHarp Clinical Solutions | Chicago | Illinois | 60649-4718 | — |
| IU Health Ball Memorial Physicians Pulmonary and Critical Care Medicine | Muncie | Indiana | 47303-3432 | — |
| Benchmark Research - Covington - HyperCore - PPDS | Covington | Louisiana | 70433-2353 | — |
| University of Maryland Medical Center | Baltimore | Maryland | 21201-1544 | — |
| Howard County Center for Lung and Sleep Medicine, LLC | Columbia | Maryland | 21044-3081 | — |
| Howard County Center for Lung and Sleep Medicine, LLC | Columbia | Maryland | 21045-5422 | — |
| Hudson County Clinical Trials Research Center | Union City | New Jersey | 07087-3375 | — |
| Duke University Medical Center | Durham | North Carolina | 27710-4000 | — |
| Southeastern Research Center | Winston-Salem | North Carolina | 27103-4029 | — |
| Baylor Scott and White Health - Advanced Lung Disease Specialists - Dallas | Dallas | Texas | 75246-2073 | — |
| Metroplex Pulmonary and Sleep Medicine Center-4833 Medical Center Dr | McKinney | Texas | 75069-1898 | — |
| Metroplex Pulmonary and Sleep Medicine Centre 4833 Medical Center Dr | McKinney | Texas | 75069-1898 | — |
| University of Utah - PPDS | Salt Lake City | Utah | 84108-1257 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 36 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05951296, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 9, 2025 · Synced Nov 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.